07/08/2014 - 10:42am
Purdue Pharma granted priority review designation for abuse-deterrent hydrocodone tablet

Purdue Pharma on Tuesday announced that the Food and Drug Administration has granted priority review designation for the company's once-daily, single-entity hydrocodone bitartrate tablet. 

07/08/2014 - 10:15am
Centor is the new name for Rexam Prescription Products, company announces

Rexam Prescription Products on Tuesday is changing its name to Centor, the company announced.

07/08/2014 - 10:03am
Mylan launches generic Micardis tablets

Mylan announced the launch of telmisartan tablets USP, which is used to treat hypertension.

07/07/2014 - 6:50pm
FDA approves Novo Nordisk's drug for rare bleeding disorder

Novo Nordisk on Monday announced that the Food and Drug Administration approved the company's NovoSeven RT (coagulation factor VIIa [recombinant]).

07/07/2014 - 6:31pm
Sandoz launches generic Diovan tabs

Sandoz announced the launch of valsartan tablets, an authorized generic version of Diovan tablets which is used for the treatment of high blood pressure.

07/07/2014 - 1:23pm
Report: ACIP recommends FluMist over traditional flu shot for healthy children ages 2 years to 8 years

According to a report from the American Academy of Family Physicians, the Advisory Committee on Immunization Practices for the Centers for Disease Control and Prevention voted unanimously to recommend that healthy children between the ages of 2 years and 8 years be inoculated with a live attenuated influenza vaccine like FluMist, as opposed to the traditional flu shot. 

07/03/2014 - 12:48pm
FDA seeks public comment regarding four-year strategic priority document

The Food and Drug Administration on Tuesday made available a draft of its strategic priorities over the next four years for public comment.

07/03/2014 - 12:30pm
FDA grants accelerated approval to Beleodaq

The Food and Drug Administration on Thursday announced approval for Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma.

07/03/2014 - 11:53am
Novartis shipping 30 million doses of influenza vaccine well ahead of 2014-2015 season

Novartis on Wednesday announced that it has begun shipment of its seasonal influenza vaccines to customers in the U.S. market for the 2014-2015 season.

07/03/2014 - 11:36am
Impax Labs acquires two generic products from Actavis

Impax Labs on Wednesday announced that it has acquired from Actavis two generic products for cash consideration. Financial terms of the agreement were not disclosed.